This brand name is authorized in Nigeria.
The drug GLAVOX contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
804826J2HU - AMOXICILLIN
|
|
Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death. |
|
2
|
UNII
Q42OMW3AT8 - CLAVULANATE POTASSIUM
|
|
Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| C4-0413 | Tablet | GLAVOX TABLET TAB 500 mg; 125 mg TABLETS 2 X 7 | GLAVOX TABLET GLAVOX AMOXICILLIN TRIHYDRATE BP EQ. TO AMOXICILLIN 500MG, POTASSIUM CLAVULANATE BP 125MG POM TABLETS 2 X 7 ANTIBIOTICS GLACK PHARMA LTD., 13 FUNSHO STREET, YABA, LAGOS. BROOKS LABORATORIES LIMITED VILLAGE KISHANPURA, NALAGARH ROAD, BADDI- 174 101 (H.P), INDIA GMP- RBC LR- SATIS; FEES- PAID; NP: NA 11/07/2016 R R R C4-0413 | 30/01/2020 |
| C4-0414 | Powder for suspension | GLAVOX POWDER FOR ORAL SUSPENSION PWD_F_SOL 200 mg/5 mL; 28.5 mg/5 mL 1 X 70ML | GLAVOX POWDER FOR ORAL SUSPENSION GLAVOX AMOXICILLIN TRIHYDRATE USP EQ. TO AMOXICILLIN 200MG, CLAVULANATE POTASSIUM USP EQ. TO CLAVULANIC ACID 28.50MG POM POWDER FOR ORAL SUSPENSION 1 X 70ML ANTIBIOTICS GLACK PHARMA LTD., 13 FUNSHO STREET, YABA, LAGOS. BROOKS LABORATORIES LIMITED VILLAGE KISHANPURA, NALAGARH ROAD, BADDI- 174 101 (H.P), INDIA GMP- RBC LR- SATIS; FEES- PAID; NP: NA 11/07/2016 R R R C4-0414 | 30/01/2020 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01CR02 | Amoxicillin and enzyme inhibitor | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | C4-0413, C4-0414 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.